Assunta Dr Imperato
#148,124
Most Influential Person Now
Assunta Dr Imperato's AcademicInfluence.com Rankings
Assunta Dr Imperatobiology Degrees
Biology
#10877
World Rank
#14237
Historical Rank
Neuroscience
#1730
World Rank
#1784
Historical Rank
Download Badge
Biology
Why Is Assunta Dr Imperato Influential?
(Suggest an Edit or Addition)Assunta Dr Imperato's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. (1988) (4597)
- Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. (1999) (1323)
- Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. (1988) (928)
- Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. (1986) (874)
- Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. (1986) (719)
- Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats (1989) (562)
- Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats (1995) (473)
- Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites (1984) (452)
- Changes in brain dopamine and acetylcholine release during and following stress are independent of the pituitary-adrenocortical axis (1991) (340)
- Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. (1985) (300)
- Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats. (1985) (284)
- Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse (2001) (269)
- Repeated stressful experiences differently affect limbic dopamine release during and following stress (1992) (265)
- Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely-moving rats (1990) (253)
- Acute stress induces time-dependent responses in dopamine mesolimbic system (1991) (225)
- NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus. (1990) (225)
- Stress-induced enhancement of dopamine and acetylcholine release in limbic structures: role of corticosterone. (1989) (210)
- Enhancement of memory in cannabinoid CB1 receptor knock-out mice. (1999) (196)
- Preferential Stimulation of Dopamine Release in the Nucleus Accumbens by Opiates, Alcohol, and Barbiturates: Studies with Transcerebral Dialysis in Freely Moving Rats (1986) (189)
- Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors. (1998) (174)
- Impaired long-term potentiation induction in dentate gyrus of calretinin-deficient mice. (1997) (152)
- 5-HT3 receptors control dopamine release in the nucleus accumbens of freely moving rats (1989) (152)
- Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors (1999) (148)
- Effects of locally applied D-1 and D-2 receptor agonists and antagonists studied with brain dialysis. (1988) (138)
- Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats. (1988) (133)
- Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice. (1999) (122)
- Chronic cocaine alters limbic extracellular dopamine. Neurochemical basis for addiction. (1992) (106)
- Repeated stressful experiences differently affect the time-dependent responses of the mesolimbic dopamine system to the stressor (1993) (102)
- The Antioxidant Ebselen Prevents Neurotoxicity and Clinical Symptoms in a Primate Model of Parkinson's Disease (2000) (99)
- Behavioural effects of GABA-agonists and antagonists infused in the mesencephalic reticular formation - deep layers of superior colliculus (1981) (98)
- Acetyl-l-carnitine enhances acetylcholine release in the striatum and hippocampus of awake freely moving rats (1989) (90)
- Effects of cocaine and amphetamine on acetylcholine release in the hippocampus and caudate nucleus. (1993) (84)
- Stimulation of both dopamine D1 and D2 receptors facilitates in vivo acetylcholine release in the hippocampus (1993) (82)
- Stress activation of limbic and cortical dopamine release is prevented by ICS 205-930 but not by diazepam. (1990) (76)
- CHRONIC ETHANOL CONSUMPTION IN RATS: CORRELATION BETWEEN MEMORY PERFORMANCE AND HIPPOCAMPAL ACETYLCHOLINE RELEASE IN VIVO (1996) (73)
- Glutamate uptake is decreased tardively in the spinal cord of FALS mice (1998) (69)
- A re-evaluation of the role of superior colliculus in turning behaviour (1982) (67)
- Automated brain dialysis of acetylcholine in freely moving rats: detection of basal acetylcholine. (1987) (67)
- The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats. (1987) (62)
- Modulation of basal and stress-induced release of acetylcholine and dopamine in rat brain by abecarnil and imidazenil, two anxioselective gamma-aminobutyric acidA receptor modulators. (1995) (61)
- The effects of clozapine and fluperlapine on the in vivo release and metabolism of dopamine in the striatum and in the prefrontal cortex of freely moving rats. (1989) (59)
- Neuroprotective effect of riluzole in a primate model of Parkinson's disease: Behavioral and histological evidence (2002) (57)
- L-α-glycerylphorylcholine antagonizes scopolamine-induced amnesia and enhances hippocampal cholinergic transmission in the rat (1992) (55)
- Inhibition of hippocampal acetylcholine release by benzodiazepines: antagonism by flumazenil. (1993) (51)
- Biochemical and behavioural properties of clozapine (2004) (48)
- Role of dorsal mesencephalic reticular formation and deep layers of superior colliculus as out-put stations for turning behaviour elicited from the substantia nigra pars reticulata (1981) (45)
- Reduction of dopamine release and synthesis by repeated amphetamine treatment: role in behavioral sensitization. (1996) (44)
- Role of dorsal mesencephalic reticular formation and deep layers of superior colliculus in turning behaviour elicited from the striatum (1981) (42)
- Evidence that neuroleptics increase striatal acetylcholine release through stimulation of dopamine D1 receptors. (1993) (42)
- The benzodiazepine receptor antagonist flumazenil increases acetylcholine release in rat hippocampus (1994) (40)
- Opposite effects of stress on dopamine release in the limbic system of drug-naive and chronically amphetamine-treated rats. (1997) (38)
- Riluzole prolongs survival and delays muscle strength deterioration in mice with progressive motor neuronopathy (pmn) (2000) (37)
- Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice (1997) (36)
- Cocaine releases limbic acetylcholine through endogenous dopamine action on D1 receptors. (1992) (36)
- Rapid increase in basal acetylcholine release in the hippocampus of freely moving rats induced by withdrawal from long-term ethanol intoxication (1998) (35)
- Strain-dependent effects of dopamine agonists on acetylcholine release in the hippocampus: An in vivo study in mice (1996) (34)
- Role of GABA neurons in the expression of striatal motor functions. (1981) (34)
- The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP+ accumulation (2000) (34)
- Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis (1985) (34)
- Cannabinoid penetration into mouse brain as determined by ex vivo binding. (1999) (33)
- L-alpha-glycerylphosphorylcholine antagonizes scopolamine-induced amnesia and enhances hippocampal cholinergic transmission in the rat. (1992) (30)
- Does dopamine exert a tonic inhibitory control on the release of striatal acetylcholine in vivo? (1994) (30)
- Role of substantia nigra pars reticulata neurons in the expression of neuroleptic-induced catalepsy (1981) (29)
- The central cholinergic system has a role in the antinociception induced in rodents and guinea pigs by the antimigraine drug sumatriptan. (1996) (29)
- Immunohistochemical analysis of presenilin 2 expression in the mouse brain: distribution pattern and co-localization with presenilin 1 protein (1997) (29)
- Rapid tolerance to neuroleptic-induced stimulation of dopamine release in freely moving rats. (1985) (27)
- Cortical and limbic dopamine and acetylcholine release as neurochemical correlates of emotional arousal in both aversive and non-aversive environmental changes (1992) (26)
- Chronic morphine increases hippocampal acetylcholine release: possible relevance in drug dependence. (1996) (24)
- Hemisynaptic distribution patterns of presenilins and β‐APP isoforms in the rodent cerebellum and hippocampus (2000) (23)
- Enoxaparin Reduces Cerebral Edemaafter Photothrombotic Injury in the Rat (1998) (20)
- Fastigial influences on postural tonus as studied by kainate lesions and by local infusion of GABAergic drugs in the rat (1984) (19)
- Neuroleptics cause stimulation of dopamine D1 receptors and their desensitization after chronic treatment. (1994) (19)
- In Vivo Probing of the Brain Cholinergic System in the Aged Rat (1991) (18)
- Pharmacology: Ouabain‐induced Increase in Dopamine Release from Mouse Striatal Slices is Antagonized by Riluzole (1998) (17)
- Differential effects of abecarnil on basal release of acetylcholine and dopamine in the rat brain. (1994) (16)
- Effects of Ebselen, a Glutathione Peroxidase Mimic, in Several Models of Mitochondrial Dysfunction (1999) (16)
- Indeno[1,2-b]pyrazin-2,3-diones: a new class of antagonists at the glycine site of the NMDA receptor with potent in vivo activity. (2000) (14)
- Spiro-imidazo[1,2-a]indeno[1,2-e]pyrazine-4-one derivatives are mixed AMPA and NMDA glycine-site antagonists active in vivo. (1999) (14)
- Benzodiazepines prevent kainate-induced loss of GABAergic and cholinergic neurons in the chick retina (1981) (13)
- Effects of subchronic minaprine on dopamine release in the ventral striatum and on immobility in the forced swimming test (1994) (13)
- Role of ventral mesencephalic reticular formation and related noradrenergic and serotonergic bundles in turning behaviour as investigated by means of kainate, 6-hydroxydopamine and 5,7-Dihydroxytryptamine lesions (1983) (13)
- 4,10-Dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazin-2-carboxylic acid derivatives: highly potent and selective AMPA receptors antagonists with in vivo activity. (2000) (13)
- 8-Methylureido-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazines: highly potent in vivo AMPA antagonists. (2000) (10)
- Synthesis and pharmacological properties of 5H,10H‐imidazo[1,2‐a]indeno[1,2‐e]pyrazine‐4‐one, a new competitive AMPA/KA receptor antagonist (1999) (10)
- Effect of barbiturates and benzodiazepines on local kainate toxicity in the striatum and in the retina. (1981) (10)
- CY 208-243, a novel dopamine D-1 receptor agonist, fails to modify dopamine release in freely moving rats. (1989) (9)
- The effect of riluzole and mannitol on cerebral oedema after cryogenic injury in the mouse (1999) (9)
- Co-dergocrine (Hydergine) regulates striatal and hippocampal acetylcholine release through D2 receptors. (1994) (9)
- Role of Cannabinoid CB1 Receptor in Morphine Rewarding Effects in Mice (2000) (7)
- P.6.041 In vitro and in vivo characterization of CP-154,526, a non-peptide CRF1 receptor antagonist with partial agonist properties (1997) (6)
- The therapeutic applications of cannabinoid agonists and antagonists (1998) (6)
- Is in vivo striatal acetylcholine output under a tonic inhibitory control by dopamine? (1995) (6)
- 8-Methylureido-10-amino-10-methyl-imidazo[1,2-a]indeno[1,2-e] pyrazine-4-ones: highly in vivo potent and selective AMPA receptor antagonists. (2000) (4)
- Aging of the Cholinergic Synapse in the Rat’s Hippocampus: Effect of Acetyl-L-Carnitine (1991) (3)
- Pharmacological properties of RPR 102681, a novel CCK-B receptor antagonist (1997) (2)
- Evaluation of cortical and hippocampal acetylcholine release during the sleep-wake cycle in freely moving cats: and EEG-dialysis study (1995) (2)
- 4,10-Dihydro-4-oxo-4 H-imidazo[1,2- a]indeno[1,2- e]pyrazin-2-carboxylic acid derivatives (2000) (2)
- SDZ DOD-647, a new clozapine-like atypical neuroleptic drug (1993) (2)
- 549 Biochemical characterization of presenilins (S182 & STM2) proteins (1996) (2)
- Effects of RPR 118723, a novel antagonist at the glycine site of the NMDA receptor, in vitro. (2000) (2)
- Ordered disorder in the aged brain. (1991) (2)
- A NEW PHARMACOLOGICAL APPROACH TO THE FACILITATION OF ACETYLCHOLINE TRANSMISSION. (1992) (1)
- In vivo acetylcholine release in the dorsal striatum in the hippocampus: A pharmacological study (1988) (1)
- 2 Dopamine Release and Metabolism in Awake Rats after Systemic Neuroleptics as Studied by Brain Dialysis (1)
- Riluzole Associations and l-dopa for the treatment of Parkinson's disease (1998) (0)
- effects and mechanism of action of clozapine on central dopaminergic transmission (1992) (0)
- Applying ureidoacetamides in the preparation of drugs for treatment of drug abuse or substances giving rise to pharmacomanies or excessive use (1996) (0)
- Application of 2-aminobenzothiazoles in the treatment of Parkinson's disease and parkinsonian syndromes (1995) (0)
- Role of GABAergic Mechanisms Within Cerebellar Nucleus Fastigii in the Control of Posture and in the Mechanism of Action of Benzodiazepines (1983) (0)
- P.1.102 Is manipulation of inositol/2nd messenger system, a therapeutic strategy for bipolar disorders? Effects of lithium, carbamazepine and lamotrigine (1997) (0)
- Using pyrrolidine-derivatives for the manufacture of pharmaceuticals for treatment of drug abuse (1997) (0)
- Use of Brain Dialysis in Freely Moving Rats for Characterizing the Profile of Dopamine-receptor Agonists (1988) (0)
- Use of pyrrolidionderivater for the preparation of medicaments for the treatment of drug dependence (1997) (0)
- Use of 2-amino-6-trifluoromethoxybenzothiazol for producing a medicament for the prevention or treatment of zerebellumkrankheiten (1999) (0)
- On the Role of Mesencephalic Reticular Formation and Superior Colliculus in the Expression of Dopaminergic Behavioural Syndromes (1982) (0)
- Use of selenium compounds in the prevention and treatment of Alzheimer's disease (1998) (0)
- Neurochemical profile of amiridime - A new drug for dementia treatment (1995) (0)
- Application of thalidomide for the treatment of parkinson's disease and parkinsonian syndromes (1996) (0)
- Motor and postural effects of kainic acid or GABA agonist and antagonist injection into the cerebellar nucleus fastigii. (1983) (0)
- THE BEHAVIOURAL EFFECTS OF MINAPRINE MAY DEPEND ON SENSITIZATION OF BRAIN DOPAMINE SYSTEMS (1993) (0)
- SELECTIVE STIMULATION OF FOS-LIKE IMMUNOREACTIVITY BY ADENOSINE A2 AGONISTS IN MESOLIMBIC AREAS (1996) (0)
- Use of 2-amino-6-trifluoromethoxy for the prevention or treatment of cerebellar dysfunction (1999) (0)
- 58 Presenilin 1 and presenilin 2 in the mouse and rat brain (1996) (0)
- Selective excitatory aminoacid agonists and antagonists on dopaminergic neurotransmission: Possible clinical implications (1990) (0)
- Impaired LTP in the dentate gyrus of calretinin deficient mice (1998) (0)
- [Motor and postural effects in intracerebellar injection of kainic acid: possible role of the bulbar reticular formation]. (1983) (0)
- 5 ht-3 antagonist for the treatment or reduction of dependence (1988) (0)
- New animal model of Alzheimer's disease presenting in both amyloid plaques and mitochondrial dysfunction (1999) (0)
- EFFECT OF NEUROLEPTICS AND DOPAMINERGIC AGONISTS AND THEIR COMBINATION ON DA-RELEASE AND METABOLISM IN AWAKE RATS: HINTS FOR THERAPEUTIC APPLICATION (1984) (0)
- Novel therapeutic application of antagonists of substance p (1996) (0)
- Pharmacological properties of SDZ 212-327, a novel antipsychotic candidate (1991) (0)
- EFFECTS OF L‐&agr;‐GLYCERYL‐PHOSPHORYL‐CHOLINE ON BRAIN CHOLINERGIC FUNCTION AND CORRELATION WITH BEHAVIORAL EFFECTS IN MEMORY TESTS (1992) (0)
- Riluzole as a Neuroprotective Therapy in Animal Models of Parkinson’s Disease (2000) (0)
- KETAMINE MODULATES WEAK ASSOCIATIONS BETWEEN STIMULI IN CONDITIONED TASTE AVERSION (1996) (0)
- Use of 5HT-3 antagonists (1988) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Assunta Dr Imperato?
Assunta Dr Imperato is affiliated with the following schools:
